NuVasive Inc. (NUVA)

69.31
NASDAQ : Health Technology
Prev Close 69.31
Day Low/High 0.00 / 0.00
52 Wk Low/High 44.62 / 72.12
Avg Volume 583.20K
Exchange NASDAQ
Shares Outstanding 51.42M
Market Cap 3.52B
EPS 1.60
P/E Ratio 87.69
Div & Yield N.A. (N.A)

Latest News

Scott Huennekens To Join NuVasive Board Of Directors

Scott Huennekens To Join NuVasive Board Of Directors

New board appointment brings expertise in surgical robotics, data analytics and medical device commercialization

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility

NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility

GE Healthcare veteran joins NuVasive to further its goal of operational excellence

NuVasive And Siemens Healthineers Partner To Transform Spine Surgery

NuVasive And Siemens Healthineers Partner To Transform Spine Surgery

Spine Precision Partnership™ to advance clinical outcomes in spine procedures through the novel integration of 3D imaging, navigation and surgical automation

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:

NuVasive Announces Second Quarter 2018 Financial Results

NuVasive Announces Second Quarter 2018 Financial Results

SAN DIEGO, July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for...

NuVasive Unveils Spine's First Integrated Surgical Automation Platform

NuVasive Unveils Spine's First Integrated Surgical Automation Platform

Pulse™ platform receives 510(k) clearance addressing spine technology and clinical requirements across all spine procedures

Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

The latest advancement of MAGEC® delivers improved rod strength together with internal rod mechanism advancements

NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation

NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation

The launch of Reline® MAS® Midline delivers procedural versatility in a compact midline construct

NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results

NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results

SAN DIEGO, July 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release...

NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018

NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018

XLX™ ACR® receives FDA 510(k) clearance and broadens expandable portfolio to include lateral procedures

Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions

Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions

Peer-reviewed article validates effectiveness of the NuVasive® Integrated Global Alignment platform

First Porous PEEK Spinal Implant Clinical Study Validates NuVasive Advanced Materials Science Technology In Treating Degenerative Cervical Disc Disease

First Porous PEEK Spinal Implant Clinical Study Validates NuVasive Advanced Materials Science Technology In Treating Degenerative Cervical Disc Disease

Cohere® interbody fusion study results now available in the Journal of Spine & Neurosurgery

NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use

NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use

Optimized surface technology promotes bone growth without added growth factors

NuVasive Announces Key Finance Appointments

NuVasive Announces Key Finance Appointments

SAN DIEGO, June 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointments of Lisa...

NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference

NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference

SAN DIEGO, June 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will...

NuVasive PRECICE STRYDE™ System Used In First Patient For Stature Lengthening By International Limb Lengthening Expert

Dr. Dror Paley, MD, FRCSC uses new minimally invasive system to treat patients for stature lengthening and limb reconstruction

NuVasive Unveils Newest Additions To Early Onset Scoliosis Portfolio At POSNA Annual Meeting

MAGEC® X joins LessRay® and the RELINE® portfolio in expansion of the NuVasive pediatric procedural solutions

NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations

Lateral Single-Position surgery and Surgical Intelligence™ take center stage at conference

NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations

NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations

Lateral Single-Position solutions and Porous PEEK™ interbody among innovations to be highlighted at global event

NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches

NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches

ALIF Access aligns with Company's focus on single-position surgery

TheStreet Quant Rating: B (Buy)